IHH Healthcare Berhad (5225.KL)
| Previous close | 6.19 |
| Open | 6.14 |
| Bid | 6.18 x 0 |
| Ask | 6.21 x 0 |
| Day's range | 6.17 - 6.24 |
| 52-week range | 5.69 - 6.43 |
| Volume | |
| Avg. volume | 5,151,242 |
| Market cap | 54.427B |
| Beta (5Y monthly) | 0.14 |
| PE ratio (TTM) | 23.77 |
| EPS (TTM) | 0.26 |
| Earnings date | 27 Aug 2024 - 02 Sept 2024 |
| Forward dividend & yield | 0.16 (2.58%) |
| Ex-dividend date | 26 Mar 2024 |
| 1y target est | 2.73 |
GlobeNewswireIHH reports highest ever quarterly revenue in Q1 2024, with double-digit growth across key metrics, on outstanding performance across all markets
KUALA LUMPUR, Malaysia and SINGAPORE, May 29, 2024 (GLOBE NEWSWIRE) -- Revenue at RM6.0 billion mark for the first timeOutstanding growth momentum: revenue up 16%, EBITDA up 19%Core profit or PATMI (ex EI) up 22%; Lower headline PATMI due to high base in previous period (Q1 2023) which included one-off gain from sale of non-core asset IMU “We carried strong growth momentum into Q1 2024, with quarterly revenue hitting the RM6.0 billion mark for the first time. This outstanding performance cut acr
GlobeNewswireIHH Spearheads Cancer Care Leadership in Asia With Official Launch of Region’s First Private Proton Therapy Centre
Mount Elizabeth Novena Proton Therapy Centre Opening From left to right:1. Sherrie Lim, Chief Executive Officer, Mount Elizabeth Novena Hospital2. Dr Peter Chow, Chief Executive Officer, IHH Healthcare Singapore3. Tan Sri Mohammed Azlan bin Hashim, Chairman, IHH Healthcare4. Dr Prem Kumar Nair, Group Chief Executive Officer, IHH Healthcare5. Tomo Nagahiro, Board member, IHH Healthcare6. Yong Yih Ming, Chief Operating Officer, IHH Healthcare Singapore Mount Elizabeth Novena Proton Therapy Centre
